What is the appropriate evaluation and management for a patient presenting with sharp, knife‑like pain?

Evaluation and Management of Sharp, Knife-Like Pain

Sharp, knife-like pain suggests a lower likelihood of cardiac ischemia, but you must still perform an initial assessment to triage effectively based on the probability of myocardial ischemia and rule out life-threatening causes before attributing symptoms to benign etiologies. 1

Initial Characterization of the Pain

Sharp pain described as knife-like, fleeting, related to inspiration (pleuritic), positional, or shifting locations points away from ischemia 1. However, this characteristic alone cannot exclude serious pathology:

• Cardiac ischemia typically produces deep, diffuse, difficult-to-localize substernal discomfort—not sharp or knife-like pain 1
• Point tenderness further reduces the likelihood of ischemia 1
• Avoid the term "atypical chest pain"—instead classify as cardiac, possibly cardiac, or noncardiac to prevent misinterpretation as benign 1

Focused Physical Examination to Identify Life-Threatening Causes

Perform a cardiovascular examination immediately to detect complications and serious diagnoses 1:

Life-Threatening Conditions That May Present With Sharp Pain

• Aortic dissection: Sudden severe chest or back pain with limb pulse differential (though pulse differential has only 30% sensitivity) 1
• Pulmonary embolism: Tachycardia (>90% of patients), dyspnea, pain with inspiration, accentuated P2 1
• Pericarditis: Sharp pain that increases when supine, may have friction rub 1
• Pneumothorax: Pleuritic sharp pain with unilateral absence of breath sounds 1
• Esophageal rupture: Sharp pain with painful, tympanic abdomen 1
• Pneumonia: Localized pleuritic pain with friction rub 1

Musculoskeletal Causes

• Costochondritis: Tenderness to palpation of costochondral joints 1
• Herpes zoster: Painful rash in dermatomal distribution 1

Risk Stratification and Cardiac Workup

Even when pain characteristics suggest low ischemic probability, you must stratify risk systematically:

ECG and Troponin Testing

• Obtain high-sensitivity cardiac troponin (hs-cTn) at presentation and repeat at 3–6 hours after symptom onset 2
• Initial hs-cTn achieves 82–91% sensitivity for acute myocardial infarction (AMI), rising to 96–100% after serial measurements 2
• 10–15% of true AMI patients have normal initial troponin—serial measurements are mandatory 2
• A rise or fall of ≥20% between measurements is required to diagnose acute myocardial injury 2

Risk Score Application

• Calculate a modified HEART score: a score ≤3 with normal serial troponins identifies low-risk patients (<1% 30-day major adverse cardiac event risk) suitable for discharge with outpatient testing 3
• Alternatively, use EDACS <16 with normal serial hs-cTn for safe discharge 3

Disposition Algorithm

For Low-Risk Patients (HEART ≤3, Normal Serial Troponins, Nonischemic ECG)

Discharge with outpatient non-invasive testing within 72 hours to 2 weeks 3:

• Choose coronary CT angiography (CCTA) when:

  • No known coronary artery disease (CAD), no prior stents or bypass grafting 3
  • Heart rate can be lowered to <65 bpm 3
  • No severe renal impairment or contrast allergy 3
  • CCTA provides >95% negative predictive value for CAD 3

• Choose stress testing with imaging when:

  • Known CAD or prior revascularization (need to assess inducible ischemia) 3
  • Contraindications to CCTA exist 3
  • Functional assessment is the clinical priority 3
  • Stress echocardiography or nuclear perfusion offers superior prognostic value over exercise ECG alone 3

For Patients Who Cannot Be Discharged

Do not discharge if any of the following develop during observation 3:

• Recurrent ischemic chest pain
• New ECG abnormalities suggesting ischemia
• Rising troponin levels on repeat testing
• Hemodynamic instability

These patients require continued observation or inpatient evaluation 3.

For High-Risk Features

Patients with ongoing chest pain, dynamic ECG changes, markedly elevated troponin, or hemodynamic instability require urgent invasive coronary angiography within 24 hours—not stress testing or CCTA 3.

Critical Pitfalls to Avoid

• Never assume sharp pain is benign without systematic evaluation for life-threatening causes (dissection, PE, pneumothorax, pericarditis) 1
• Do not rely on a single troponin value—serial measurements are essential because 10–15% of AMI patients have normal initial levels 2
• Do not use point-of-care troponin assays for ruling out AMI—they have substantially lower sensitivity than central-laboratory hs-cTn 2
• Patients presenting within 2–3 hours of symptom onset may be on the downslope of troponin release and require extended monitoring (up to 26% will not show a falling pattern over short intervals) 2
• CCTA is not validated for patients with prior stents or bypass grafts, and heavy calcification impairs interpretation 3
• Stress testing should not be performed in patients with ongoing pain, dynamic ECG changes, or rising troponin 3